Recently, Yidu Technology (2158., a leading enterprise in China's medical intelligence industryHK) announced its FY2024 interim results. In the middle of fiscal year 2024, the company's total revenue was RMB35.6 billion yuan, adjusted net loss narrowed to 54.1 million yuan, a year-on-year decrease of 759%。Among them, the big data platform and solutions segment, as the infrastructure sector of Yidu Technology with the longest cultivation, generated revenue of RMB1$2.8 billion.
As of September 30, 2023, Yiducore, the self-developed "medical intelligent brain" Yiducore has covered more than 1,700 hospitals, of which the total number of customers of leading research hospitals has increased to 94, and the number of customers of regulators and policy makers has increased to 38.
In terms of providing high-quality applications and solutions for hospitals, Yidu Technology mainly focuses on three key scenarios: research, clinical diagnosis and hospitalization, as well as hospital operation and management. It is worth noting that during the reporting period, Yidu Technology continued to promote the commercialization and promotion of a new generation of hospital scenario intelligent solutions, and the "all-disease database platform" deeply empowers medical scientific research, providing full-process scientific research tools such as inspiration discovery, multi-modal medical record search, intelligent extraction, follow-up, statistical analysis and artificial intelligence modeling, which have been deployed and applied in many leading research hospitals and tertiary hospitals, and have been deeply used by more than 250 clinical research teams. In addition, Yidu Technology has successively built a "whole disease database platform" and "yidueywa2." for a tertiary hospital in East China0", to meet the scientific research needs of the whole hospital in different dimensions, and improve the hospital's data asset management capabilities and the hospital's refined operation level.
The company has continuously deepened its research in key disease areas, and in the field of hematology, it has won the bid for the national multi-center big data platform project for national blood system diseases in a tertiary hospital in East China, with a contract amount of nearly RMB 9 million. In addition, in the field of ophthalmic diseases, the "Big Data Platform of the National Clinical Research Center for Eye Diseases" undertaken by the company was officially released during the reporting period. Yidu Technology has also won the bid for a number of special disease bank projects of tertiary and first-class hospitals, expanding its research capabilities in the fields of pediatrics, respiratory medicine, nephrology and other diseases.
For regulators and policymakers, Yidu Technology provides AI-empowered data analysis-driven solutions, covering national, provincial and city-level regional platform construction and public health. During the reporting period, Yidu Technology further won the bid for the medical supervision platform project in Chaoyang District, Beijing, and on the basis of the medical big data platform in Chaoyang District, it helped build an operation supervision and analysis system for medical and health institutions, and strengthened the intelligent monitoring of the operation of medical institutions in the region, with a contract amount of nearly RMB 10 million.
Through the integration of multi-dimensional and multi-point data and a large number of disease data accumulated in the work, combined with multi-point early warning and multi-dimensional technology, Yidu Technology has assisted the province to better respond to emerging major infectious diseases, diseases of unknown causes and public health emergencies, and improve the province's epidemic monitoring, early warning and emergency response capabilities.
In the first half of fiscal year 2024, Yidu Technology's business developed steadily, the synergies between business segments were further enhanced, and the overall operational efficiency continued to improve. The company said that it will focus on the "focus" strategy, focus on core business and core customers, and further improve profitability.